NanoViricides
NNVC
#10080
Rank
NZ$44.99 M
Marketcap
NZ$2.09
Share price
6.19%
Change (1 day)
-3.38%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): NZ-$1.03

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$1.06. In 2024 the company made an earnings per share (EPS) of NZ-$1.22 an increase over its 2023 EPS that were of NZ-$1.29.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$1.03-15.35%
2024NZ-$1.22-5.41%
2023NZ-$1.295.71%
2022NZ-$1.22-13.58%
2021NZ-$1.41-66.11%
2020NZ-$4.161.7%
2019NZ-$4.09-10.98%
2018NZ-$4.59-22.35%
2017NZ-$5.91-10.53%
2016NZ-$6.61375%
2015NZ-$1.39-85.19%
2014NZ-$9.3942.11%
2013NZ-$6.6126.67%
2012NZ-$5.22-6.25%
2011NZ-$5.5614.28%
2010NZ-$4.87100%
2009NZ-$2.43-0%
2008NZ-$2.43-33.33%
2007NZ-$3.65-0%
2006NZ-$3.654445.07%
2005NZ-$0.08033

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ-$0.08692-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$3.69-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.34-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.16-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.20-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.25-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK